POLYVASCULAR DISEASE WITH AND WITHOUT DIABETES AND THE RISK OF ADVERSE CARDIOVASCULAR AND LIMB EVENTS IN THE EUCLID TRIAL

Polyvascular disease (PVD) and diabetes mellitus (DM) are additive for the risk of major adverse cardiovascular events (MACE) in patients with coronary disease. Whether this risk relationship for MACE as well as for amputation is also true in symptomatic peripheral artery disease (PAD) is not well